ArticleFrontiers in oncology2022

Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma.

Longjiang She et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.